{"id":73472,"date":"2023-06-05T11:41:07","date_gmt":"2023-06-05T15:41:07","guid":{"rendered":"https:\/\/wfh.org\/article\/speaker\/angela-weyland\/"},"modified":"2023-08-15T13:36:48","modified_gmt":"2023-08-15T17:36:48","slug":"angela-weyland","status":"publish","type":"speaker","link":"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/","title":{"rendered":"Angela Weyand"},"content":{"rendered":"

Associate Professor
Department of Pediatrics, University of Michigan
United States<\/p>\n","protected":false},"excerpt":{"rendered":"

Dr. Weyand is a native of Kansas City, Kansas and graduate of Northwestern University in Evanston, Illinois. She attended medical school at the University of Michigan and completed her pediatrics residency at the University of Washington\/Seattle Children’s Hospital. She then returned to the University of Michigan for pediatric hematology and oncology fellowship and subsequently stayed on as faculty. Clinically, she is interested in von Willebrand disease and young women and girls with bleeding or clotting disorders. She is co-director of a combined hematology\/gynecology program and co-chair of the NHF working group to identify a national research blueprint to address the needs of this population. Her research interests are in women and girls with bleeding disorders, hormone provoked thrombosis, and von Willebrand disease. She was a member of the management panel for the latest ASH\/ISTH\/NFH\/WFH VWD guidelines, a co-chair for the ISTH SSC on Women’s Health, and Theme Lead for Women’s Health for the ISTH 2025 meeting.<\/p>\n","protected":false},"featured_media":73159,"template":"","meta":{"inline_featured_image":false},"speaker-type":[268,270],"class_list":["post-73472","speaker","type-speaker","status-publish","has-post-thumbnail","hentry","speaker-type-all-speakers-es","speaker-type-speakers-es"],"yoast_head":"\nAngela Weyand | FMH - Federaci\u00f3n Mundial de Hemofilia<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Angela Weyand\" \/>\n<meta property=\"og:description\" content=\"Dr. Weyand is a native of Kansas City, Kansas and graduate of Northwestern University in Evanston, Illinois. She attended medical school at the University of Michigan and completed her pediatrics residency at the University of Washington\/Seattle Children's Hospital. She then returned to the University of Michigan for pediatric hematology and oncology fellowship and subsequently stayed on as faculty. Clinically, she is interested in von Willebrand disease and young women and girls with bleeding or clotting disorders. She is co-director of a combined hematology\/gynecology program and co-chair of the NHF working group to identify a national research blueprint to address the needs of this population. Her research interests are in women and girls with bleeding disorders, hormone provoked thrombosis, and von Willebrand disease. She was a member of the management panel for the latest ASH\/ISTH\/NFH\/WFH VWD guidelines, a co-chair for the ISTH SSC on Women's Health, and Theme Lead for Women's Health for the ISTH 2025 meeting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - Federaci\u00f3n Mundial de Hemofilia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-15T17:36:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2023\/06\/Weyand-Angela.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/\",\"url\":\"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/\",\"name\":\"Angela Weyand | FMH - Federaci\u00f3n Mundial de Hemofilia\",\"isPartOf\":{\"@id\":\"https:\/\/wfh.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2023\/06\/Weyand-Angela.jpg\",\"datePublished\":\"2023-06-05T15:41:07+00:00\",\"dateModified\":\"2023-08-15T17:36:48+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/#primaryimage\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2023\/06\/Weyand-Angela.jpg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2023\/06\/Weyand-Angela.jpg\",\"width\":800,\"height\":800},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wfh.org\/es\/#website\",\"url\":\"https:\/\/wfh.org\/es\/\",\"name\":\"FMH - Federaci\u00f3n Mundial de Hemofilia\",\"description\":\"WFH - World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/wfh.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wfh.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wfh.org\/es\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\/\/wfh.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/wfhemophilia\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Angela Weyand | FMH - Federaci\u00f3n Mundial de Hemofilia","robots":{"index":"noindex","follow":"follow"},"og_locale":"es_ES","og_type":"article","og_title":"Angela Weyand","og_description":"Dr. Weyand is a native of Kansas City, Kansas and graduate of Northwestern University in Evanston, Illinois. She attended medical school at the University of Michigan and completed her pediatrics residency at the University of Washington\/Seattle Children's Hospital. She then returned to the University of Michigan for pediatric hematology and oncology fellowship and subsequently stayed on as faculty. Clinically, she is interested in von Willebrand disease and young women and girls with bleeding or clotting disorders. She is co-director of a combined hematology\/gynecology program and co-chair of the NHF working group to identify a national research blueprint to address the needs of this population. Her research interests are in women and girls with bleeding disorders, hormone provoked thrombosis, and von Willebrand disease. She was a member of the management panel for the latest ASH\/ISTH\/NFH\/WFH VWD guidelines, a co-chair for the ISTH SSC on Women's Health, and Theme Lead for Women's Health for the ISTH 2025 meeting.","og_url":"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/","og_site_name":"FMH - Federaci\u00f3n Mundial de Hemofilia","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_modified_time":"2023-08-15T17:36:48+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2023\/06\/Weyand-Angela.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/","url":"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/","name":"Angela Weyand | FMH - Federaci\u00f3n Mundial de Hemofilia","isPartOf":{"@id":"https:\/\/wfh.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2023\/06\/Weyand-Angela.jpg","datePublished":"2023-06-05T15:41:07+00:00","dateModified":"2023-08-15T17:36:48+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/wfh.org\/es\/article\/speaker\/angela-weyland\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2023\/06\/Weyand-Angela.jpg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2023\/06\/Weyand-Angela.jpg","width":800,"height":800},{"@type":"WebSite","@id":"https:\/\/wfh.org\/es\/#website","url":"https:\/\/wfh.org\/es\/","name":"FMH - Federaci\u00f3n Mundial de Hemofilia","description":"WFH - World Federation of Hemophilia","publisher":{"@id":"https:\/\/wfh.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/wfh.org\/es\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"]}]}},"_links":{"self":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/speaker\/73472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/speaker"}],"about":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/types\/speaker"}],"version-history":[{"count":0,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/speaker\/73472\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/media\/73159"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/media?parent=73472"}],"wp:term":[{"taxonomy":"speaker-type","embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/speaker-type?post=73472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}